MedPath

Double Stimulation in Women With Low Prognosis in ART

Not Applicable
Recruiting
Conditions
Assisted Reproductive Techniques
Interventions
Procedure: double stimulation
Procedure: conventional ovarian stimulation
Registration Number
NCT04531644
Lead Sponsor
Tu Du Hospital
Brief Summary

The main objective of this study is to compare the cumulative ongoing pregnancy rates of two different IVF protocols in women candidate for ART characterized by low prognosis.

Detailed Description

The patients will be allocated into two groups: control and study group _ In study group, patients will be treated by DuoStim protocol: The first phase of ovarian stimulation is started on the second day or third day of period. GnRH agonist will be used to trigger when at least two follicles ≥ 17 mm. Approximately 36 hours later, oocytes will be retrieved vaginally under ultrasound monitoring and ICSI will be performed. Five days later after oocyte retrieval, the second stimulation will be started. All embryos will be cryopreserved.

_ In control group, patients will be treated with antagonist protocol: The cycle of ovarian stimulation is started on the second day or third day of period. hCG will be used to trigger when at least two follicles ≥ 17 mm. Approximately 36 hours later, oocytes will be retrieved vaginally under ultrasound monitoring and ICSI will be performed. If serum progesterone on the day of trigger ≥ 1.5 ng/ml, all embryos will be cryostored; otherwise, fresh embryos will be transferred.

Recruitment & Eligibility

Status
RECRUITING
Sex
Female
Target Recruitment
100
Inclusion Criteria
  • Age ≤ 40.
  • AMH ≥ 0.3 ng/ml and ≤ 1.2 ng/ml.
  • OR 3 ≤ AFC ≤7.
  • Normal shape of uterus (based on ultrasound).
  • Body mass index within 28 - 37 kg/m2
Exclusion Criteria
  • Asherman's syndrome.
  • Endometriosis.
  • Leiomyomas distorting the endometrium
  • Sperm extracted from surgical procedures (i.e. PESA, TESE).
  • Patients refuse to continue participating in the study.
  • Patients injected with wrong dose of gonadotropins during the treatment.
  • Serious complications or accidents arise forcing the patients to discontinue the treatments.
  • Ovarian surgery
  • Previous chemotherapy or pelvic irradiation

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Studydouble stimulationthe patients in this group will be treated with double stimulation
Controlconventional ovarian stimulationthe patients in this group will be treated with conventional ovarian stimulation
Primary Outcome Measures
NameTimeMethod
Cumulative Ongoing pregnancy rateweek 11 - 14 of pregnancy

calculated by the number of ongoing pregnancy patients divided by the total number of patients in appropriate group

Secondary Outcome Measures
NameTimeMethod
Fertilization rate1 to 3 days after oocyte pick-up

number of fertilized oocyted divided by number of mature oocytes

Pregnancy rate2 weeks after embryo transfer

beta-hCG test is positive

Number of mature oocytes4 hours after oocyte pick-up

Number of mature oocytes identified by the embryologists

Ongoing pregnancy rateweek 11 - 14 of pregnancy

defined as the pregnancy completed 11 - 14 weeks of gestation and having vital fetus

Number of oocytes retrieved4 hours after occyte pick-up

Number of oocytes retrieved identified by the embryologists

Number of competent embryos3 days to 5 days after oocyte pick-up

Number of embryos that can be transferred

Trial Locations

Locations (1)

Department of Infertility of Tu Du hospital

🇻🇳

Ho Chi Minh City, Vietnam

© Copyright 2025. All Rights Reserved by MedPath